retatrutide triple agonist glp-1 gip glucagon phase 2 results hormone receptor for metabolic dysfunction-associated steatotic liver disease: a randomized 2a trial The power of three: Retatrutide's

The findings documented across preclinical trials position BPC-157 as one of the more broadly studied research compounds in the recovery and regenerative medicine space

Key Takeaways A University of Pennsylvania study used AI to analyze over 400,000 Reddit posts about GLP-1 medications and identified side effects not well-captured in clinical trials

Epidemiology Incidence affects ~0.2% of Caucasian population Demographics 4:1 male:female usually presents in 3rd decade of life Etiology Pathoanatomy exact mechanism is unknown, but most likely due to an autoimmune reaction to an environmental pathogen in a genetically susceptible individual

The protein responsible for this decision is brain-derived neurotrophic factor, commonly known as BDNF

Chat with your doctor or try Noom Med to figure out which medication aligns best with your lifestyle and goals